|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61K 45/06 | |||
| A61K 31/4545 | |||
| A61K 31/4985 | |||
| A61K 31/505 | |||
| A61K 31/519 | |||
| A61P 37/00 | |||
| A61P 29/00 |
| (11) | Number of the document | 3233103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15823107.6 |
| Date of filing the European patent application | 2015-12-18 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/066868 |
| Date | 2015-12-18 |
| (87) | Number | WO 2016/100914 |
| Date | 2016-06-23 |
| (30) | Number | Date | Country code |
| 201462093891 P | 2014-12-18 | US |
| (72) |
GOURLAY, Steven, AU
|
| (73) |
Principia Biopharma Inc.,
220 E. Grand Ave., S. San Francisco, CA 94080,
US
|
| (54) | TREATMENT OF PEMPHIGUS |
| TREATMENT OF PEMPHIGUS |